AI can double output. Human biology cannot.

In recent weeks, Accenture grabbed headlines by linking senior managers’ promotion prospects to their utilization of internal AI tools. In a market characterized by automation and efficiency, employees are expected to incorporate AI into their daily work processes. Now, usage can shape career progression.

That policy reflects a broader trend across corporate America. Companies aren’t just using AI to automate tasks. They’re using it to raise expectations regarding how much work humans should generate.

This isn’t inherently wrong. Measurement is crucial for discipline and performance. AI tools can reduce friction, eliminate low-value tasks, and clarify goals. Used carefully, they can enhance human ability.

The mistake lies elsewhere.

The danger surfaces when higher measured output is mistaken for sustainable performance. When organizations equate productivity gains with permanent increases in expectation, they effectively borrow against biological reserves. The debt is repaid later through disengagement, turnover, and diminished adaptability.

AI can double output. Human biology cannot.

The logic driving the escalation is understandable. If generative tools enable a consultant to analyze twice as much data, why not adjust targets? If coding assistants shorten development timelines, why not reset delivery schedules? If dashboards quantify performance in real time, why not precisely calibrate expectations?

The problem is that machine acceleration doesn’t automatically expand human capacity.

Human performance follows nonlinear curves. Moderate stress sharpens attention. Chronic stress degrades memory, judgment, and emotional regulation. Energy is finite. Recovery capacity is finite. Emotional bandwidth is finite. When AI increases the pace and volume of work, the biological system doesn’t scale in parallel.

Technology can compress tasks. It can’t compress recovery.

When companies use AI to process twice as much information, attend twice as many meetings, and produce twice as many deliverables, the temptation is to regard that surge as the new baseline. What was once exceptional becomes expected. What was once temporary becomes permanent.

Over time, that mismatch leads to predictable consequences. Burnout cycles increase. Absenteeism rises. Creative problem-solving narrows as cognitive load builds up. Discretionary effort declines. The very tools designed to unlock productivity start to erode the capacities that sustain it.

These effects have measurable economic consequences.

Turnover isn’t a cultural inconvenience. Replacing skilled knowledge workers can cost a significant percentage of annual compensation once recruiting fees, onboarding time, lost productivity, and team disruption are factored in. If AI-driven expectation resets increase attrition even slightly, the financial gains from higher throughput can be quickly offset by replacement costs and weakened institutional memory.

Productivity volatility also impacts earnings quality. Workers operating near physiological limits tend to produce short bursts of elevated output followed by fatigue, disengagement, or extended leave. That volatility complicates planning and weakens operational predictability. In knowledge-intensive industries, sustainable value depends less on raw throughput and more on judgment, innovation, and collaborative problem-solving. Those capabilities degrade when biological constraints are ignored.

The borrowing-against-biological-reserves dynamic is similar to financial leverage. When companies increase debt without strengthening underlying cash flow, they boost short-term returns but increase long-term fragility. Escalating output expectations without reinforcing recovery, autonomy, and trust creates a similar imbalance. Organizations may show impressive quarterly gains while quietly depleting the human capital that supports future performance.

There are also compliance and reputational risks. As firms collect more behavioral and biometric data through AI systems and wearable technologies, regulators are paying closer attention to privacy and disability protections. A breach involving health or behavioral data can quickly result in reputational damage and market value erosion. Human capital governance is increasingly part of fiduciary oversight, not a peripheral human resources issue.

None of this implies abandoning metrics. The difference lies in how they’re used.

AI should remove friction, not permanently raise the biological ceiling. It should expand strategic capacity, not compress recovery time. Metrics can discipline performance, but they can’t eliminate physiological constraints.

Trust plays a decisive role. High-trust environments reduce coordination costs and speed up execution. When monitoring seems transparent and supportive, adoption usually follows. When it seems extractive, stress responses increase and intrinsic motivation decreases. Surveillance may increase visible output in the short term, but it can quietly raise the long-term cost structure of the organization.

Investors are increasingly examining workforce stability and resilience as drivers of durable performance. Human capital disclosures now accompany financial statements in evaluating long-term value creation. A strategy based on doubling output through AI without reinforcing recovery, autonomy, and trust risks creating brittle organizations that break under pressure.

Boards and executive teams should be asking more rigorous questions as AI adoption accelerates. Are productivity gains due to friction removal or expectation escalation? Are recovery cycles built into performance systems? Are we strengthening human capital durability or consuming it for short-term gains? Over a three- to five-year period, which approach generates more stable returns?

The companies most likely to succeed in the AI era won’t be those that demand the largest productivity multiples. They’ll be those that align technological acceleration with biological sustainability.

That requires design discipline. It means building recovery cycles into performance systems. It means measuring value over multi-year horizons rather than rewarding quarterly spikes. And it means recognizing that while AI can expand analytical capacity and compress timelines, it can’t rewrite the limits of human physiology.

Organizations that ignore that constraint may achieve impressive short-term gains. They may also find that the true bottleneck in the age of artificial intelligence isn’t technological capability.

It’s the biological system expected to keep up with it.